Propylthiouracil - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for propylthiouracil and what is the scope of freedom to operate?
Propylthiouracil
is the generic ingredient in one branded drug marketed by Abbott, Actavis Elizabeth, Anabolic, Ani Pharms, Chartwell Molecular, Chartwell Rx, Endo Operations, Halsey, Impax Labs, Lilly, Macleods Pharms Ltd, Quagen, Sun Pharm Industries, Tablicaps, and Watson Labs, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for propylthiouracil. Seven suppliers are listed for this compound.
Summary for propylthiouracil
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 15 |
NDAs: | 16 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 146 |
Clinical Trials: | 12 |
Patent Applications: | 6,152 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for propylthiouracil |
What excipients (inactive ingredients) are in propylthiouracil? | propylthiouracil excipients list |
DailyMed Link: | propylthiouracil at DailyMed |
Recent Clinical Trials for propylthiouracil
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Case Comprehensive Cancer Center | Phase 2 |
Maastricht University | Phase 2 |
Maastricht University | Phase 1 |
Pharmacology for propylthiouracil
Drug Class | Thyroid Hormone Synthesis Inhibitor |
Mechanism of Action | Thyroid Hormone Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for propylthiouracil
Anatomical Therapeutic Chemical (ATC) Classes for propylthiouracil
US Patents and Regulatory Information for propylthiouracil
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080932-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecular | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080016-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Elizabeth | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080172-001 | Approved Prior to Jan 1, 1982 | BD | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lilly | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 006213-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Anabolic | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 080285-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Operations | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 006188-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm Industries | PROPYLTHIOURACIL | propylthiouracil | TABLET;ORAL | 083982-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.